2200 Pierce Avenue
Nashville, TN 37232
Phone: (877) 936-8422
Type: Hospital-basedDelegate Representative:
Ms. Anna Liza RodriguezProfile:
The mission of the Vanderbilt-Ingram Cancer Center is to alleviate cancer death and suffering through pioneering research; innovative patient-centered care; and evidence-based prevention, education and community initiatives.
Vanderbilt University Medical Center has been at the forefront of groundbreaking cancer research and treatment for decades. This legacy began with the work of Nobel laureates Earl Sutherland and Stanley Cohen, whose research in cell communication, growth and dissemination are the foundation of many of today's breakthroughs in cancer treatment. Building on that history, the Vanderbilt Cancer Center was formally established in 1993 under the leadership of Hal Moses, M.D. The Center consolidated all cancer-related research, treatment, education and outreach at Vanderbilt with the immediate objective of joining the ranks of the premier institutions designated as a Comprehensive Cancer Center by the National Cancer Institute (NCI). Two years later, Vanderbilt became the youngest center to go from creation to designation with its initial status as a "clinical cancer center." In 1999, Nashville's Ingram family made a transformational gift in honor of the late E. Bronson Ingram, philanthropist, businessman and civic leader. The center became known as the Vanderbilt-Ingram Cancer Center (VICC) in recognition of this important partnership.
In 2001, the Center earned NCI's top distinction as a Comprehensive Cancer Center, and remains one of only a fraction of such centers in the United States. In 2008, Jennifer A. Pietenpol, Ph.D., Vanderbilt Professor of Biochemistry, Cancer Biology and Otolaryngology, was named Director of the VICC. Later that year, President Obama appointed her to serve a six-year term on the NCI’s National Cancer Advisory Board. In 2007, the Center was invited to join the prestigious National Comprehensive Cancer Network, a non-profit alliance of the nation’s top centers. These centers are recognized as being at the forefront of cancer diagnosis, treatment, and support care and leading the way at conducting ground-breaking research. In July 2010, the VICC launched the Personalized Cancer Medicine Initiative, becoming the first cancer center in the Southeast to offer cancer patients routine genotyping of their tumors at the DNA level. The Center continues to be a national leader in precision medicine. In 2015, the Center successfully renewed its Comprehensive Cancer Center designation and was recognized by its peers and the NCI as one of the very best Centers in the country.
Facility and Services:
|New Cancer Patients per Year:||No Data|
|Conducts Clinic Research:||No or No Data|
|Clinical Research:||No Data|
and Co-op Group Memberships:
|Medical Oncology:||No Data|
|Treatment Chairs:||No Data|
|Treatment Beds:||No Data|
|Radiation Oncology Offered:||No Data|
|CT Simulators:||No Data|
|Linear Accelerators:||No Data|
|Radiation Oncology:||No Data|
|Breast Care Center:||No Data|
|Available Program Staff:||No Data|
|Support Services:||No Data|
|Additional Support Services:||m10992230.jpg|